Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josiane Ragimbeau

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|May 6, 2008
The Stat3-activating Tyk2 V678F mutant does not up-regulate signaling through the type I interferon receptor but confers ligand hypersensitivity to a homodimeric receptorMilica Gakovic, Josiane Ragimbeau, Véronique Francois, et al.
The EMBO Journal|January 30, 2003
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expressionJosiane Ragimbeau, Elisabetta Dondi, Andrés Alcover, et al.
The Biochemical Journal|July 14, 2007
Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2Zrinka Marijanovic, Josiane Ragimbeau, José van der Heyden, et al.
The Biochemical Journal|March 23, 2006
TYK2 activity promotes ligand-induced IFNAR1 proteolysisZrinka Marijanovic, Josiane Ragimbeau, K G Suresh Kumar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Jakmip1 is expressed upon T cell differentiation and has an inhibitory function in cytotoxic T lymphocytesValentina Libri, Dörte Schulte, Amber van Stijn, et al.
The Journal of Biological Chemistry|July 28, 2004
Jamip1 (marlin-1) defines a family of proteins interacting with janus kinases and microtubulesCorinna Steindler, Zhi Li, Michèle Algarté, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 30, 2013
Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competentZhi Li, Milica Gakovic, Josiane Ragimbeau, et al.
Journal of Leukocyte Biology|October 19, 2006
NF-{kappa}B is required for STAT-4 expression during dendritic cell maturationMaria Elena Remoli, Josiane Ragimbeau, Elena Giacomini, et al.
Journal of Leukocyte Biology|April 21, 2006
Differential responsiveness to IFN-alpha and IFN-beta of human mature DC through modulation of IFNAR expressionMartina Severa, Maria Elena Remoli, Elena Giacomini, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2003
A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunityMichael H Shaw, Victor Boyartchuk, Sandy Wong, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|May 6, 2008
The Stat3-activating Tyk2 V678F mutant does not up-regulate signaling through the type I interferon receptor but confers ligand hypersensitivity to a homodimeric receptorMilica Gakovic, Josiane Ragimbeau, Véronique Francois, et al.
The EMBO Journal|January 30, 2003
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expressionJosiane Ragimbeau, Elisabetta Dondi, Andrés Alcover, et al.
The Biochemical Journal|July 14, 2007
Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2Zrinka Marijanovic, Josiane Ragimbeau, José van der Heyden, et al.
The Biochemical Journal|March 23, 2006
TYK2 activity promotes ligand-induced IFNAR1 proteolysisZrinka Marijanovic, Josiane Ragimbeau, K G Suresh Kumar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Jakmip1 is expressed upon T cell differentiation and has an inhibitory function in cytotoxic T lymphocytesValentina Libri, Dörte Schulte, Amber van Stijn, et al.
The Journal of Biological Chemistry|July 28, 2004
Jamip1 (marlin-1) defines a family of proteins interacting with janus kinases and microtubulesCorinna Steindler, Zhi Li, Michèle Algarté, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 30, 2013
Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competentZhi Li, Milica Gakovic, Josiane Ragimbeau, et al.
Journal of Leukocyte Biology|October 19, 2006
NF-{kappa}B is required for STAT-4 expression during dendritic cell maturationMaria Elena Remoli, Josiane Ragimbeau, Elena Giacomini, et al.
Journal of Leukocyte Biology|April 21, 2006
Differential responsiveness to IFN-alpha and IFN-beta of human mature DC through modulation of IFNAR expressionMartina Severa, Maria Elena Remoli, Elena Giacomini, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2003
A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunityMichael H Shaw, Victor Boyartchuk, Sandy Wong, et al.
Pageof 2